boston745
8 hours ago
SINTX AND PRODWAYS AGREE ON CERAMIC SLURRY SUPPLY AND 3D PRINTING AGREEMENT
SINTX and its subsidiary Technology Assessment and Transfer, Inc. will supply ceramic-filled printable slurries
First off this agreement seems to be with either Sintx subsidiary TA&T or both subsidiary and parent. Considering the ceramic slurries mentioned, id say its with TA&T.
SINTX now sells 3D printed components made from alumina, zirconia, and silica, and also supplies custom printable ceramic-filled resins to customers across multiple industries. In February of 2024, the company announced a multiple year supply agreement with a leading aerospace company.
Those are all slurries provided by TA&T and as you can see this quote references the Aerospace supply agreement from February which i suspect to be with their previous R&D partner Morgan Ceramics.
SINTX will manufacture and supply key ceramic aircraft engine components which have been qualified through a rigorous evaluation process.
Thus this suggests that part of this agreement pertains to Ceramic Matrix Composites for Aero Engine Applications. If this pertains to CMCs then this agreement is likely also connected to this PR from January:
SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY
entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. Army Combat Capabilities Development Command Army Research Laboratory (DEVCOM ARL). This partnership is expected to leverage the strengths of both organizations in the areas of ceramic additive manufacturing (ceramic 3D printing) and ceramic matrix composites (CMCs).
Prodways already supplies it printers to the French Army further supporting that this agreement is conneced to the R&D agreement with US Army.
French Army installs two Prodways P1000 3D printers for manufacturing spare parts
https://3dprintingindustry.com/news/french-army-installs-two-prodways-p1000-3d-printers-for-manufacturing-spare-parts-156430/
Thus TA, there is nothing fluff about this press release. Teslas news release, however, was fluff. This is because it still doesnt have actual clearance to deploy its L2 FSD software there. According to Reuters this is fairly easy to get. The problem will be to get the data out of China. Pump Pump Pump over there.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174326772
https://i.imgur.com/slfDxL5.jpeg
Quote Sources:
https://ir.sintx.com/news-events/press-releases/detail/228/sintx-and-prodways-agree-on-ceramic-slurry-supply-and-3d
https://ir.sintx.com/news-events/press-releases/detail/223/sintx-technologies-enters-into-a-second-long-term-supply
https://ir.sintx.com/news-events/press-releases/detail/220/sintx-subsidiary-technology-assessment-transfer-to
https://web.archive.org/web/20221128231656/https://static.seekingalpha.com/uploads/sa_presentations/787/14787/original.pdf - Slides 5 & 27
========================================
3D printing Biomedical collaberation linked here:
https://ir.sintx.com/news-events/press-releases/detail/215/3dceram-sinto-inc-and-sintx-technologies-announce
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
========================================
Silicon Nitride = Next Gen Hip Implant Material
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Im guessing the authors meant Sintx Technologies. Amedica being the companies former name before the name was sold to CTL.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422432/
========================================
Electromagnetic fields, metal implant corrosion, and dis-ease it causes
https://i.imgur.com/nLg7SXT.jpg
Cancer-Causing Effects of Orthopaedic Metal Implants in Total Hip Arthroplasty
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11011042/
Oral Cancer around Dental Implants: Are the Clinical Manifestations and the Oncogenic Mechanisms Unique?
https://www.intechopen.com/chapters/79298
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779
XenaLives
17 hours ago
Thanks for the additional info...
Defense & Aerospace would be even more lucrative ( unfortunately this is the priority today's world)
Prodways is promoting dental implants, so that is covered, that appears to be plastic, but the tech is proven for bio fitting.
I was thinking bone replacement, which would be additive to the dental franchise and open up a lot of new medical business.
Perhaps it is for multiple human biological applications:
The team’s 25 years of experience makes SINTX an attractive development partner for Prodways, a manufacturer of 3D printers and a leader in the additive manufacturing industry. SINTX has been actively 3D printing ceramics with the Prodways L5000 since 2018, SINTX is excited to benefit from the technical advancements from the latest Prodways hardware innovations as part of this partnership.
Prodways, a pioneer in industrial 3D printing, will be able to leverage SINTX’s Silica and Alumina qualified slurries on the latest MovingLight machine generation, specifically developed for the demanding requirement of ceramic application. In particular, the machine will provide a unique combination of high resolution and build envelope, while maintaining process scalability with flexible build envelope configuration and process-oriented parameters control.
Ann Kutsch, General Manager of the SINTX-Maryland site, commented: “Our outstanding engineering team has 6 years of experience working with Prodways printers, and we have already used their equipment to commercialize multiple resin compositions and part designs. I expect that a more formal partnership will lead to some breakthrough developments and novel solutions for all our customers.”
Vincent Icart, CTO and COO of Prodways, added “Prodways has had a very early exposure to ceramics 3D printing. Before this partnership, we were only supplying customers with internal capabilities development. We are thrilled to bolster our specifically developed MovingLight machineries with SINTX slurries, as our joint expertise will allow us to be an end-to-end solution provider for the most demanding ceramic printing applications.”
XenaLives
17 hours ago
More interesting info...
boston745
Member Level
Re: None
Thursday, March 21, 2024 3:32:25 PM
Post# 40663 of 40935
Interesting pattern of increased attacks on me around the time of increased naked shorting of the stock; although this is not 100%. We will not know for a month, but yesterdays volume may have been accompanied by an increase in naked shorting as there was on the 21st of February. Attacks on me, i suspect are more than just to distract from what i post but also because they know that will prompt a typical response of posting information to defend Sintx real valuation. Which, they then utilize to help craft their narrative that Sintx is a scam and im paid or just crazy. However i post information regardless if the stock price drops or trades sideways here just like i post warning about Tesla on its forum regardless of which direction the stock goes. The best defense against such attacks is to read the research, which is heavily sourced, and watch the other posters in action. I include the claim that 911 was an inside job, along with the evidence that supports this claim, knowing to some this will make me look crazy, which only aids their crazy claim. However i do this purposefully.
I use evidence to point to Sintx eventual success. At the same time a counter element lead by hfunds drives the price lower via naked shorting, to aid in lowering of the VWAP strike price, and converting their warrants cashless (free shares). The funds benefit by driving the price lower to lower their VWAP and reverse split to lower it even further as seen since the 100:1 RS to end 2022. They make alot of money shorting this and get the tax write off on the original investment "loss".
Almost all posters on SINTX forums, with the exception of myself, are aligned with the goal of price going lower. In part this is so there is no collateral damage of people losing too much money on SINT; they warned me to sell early last year before they drove the price to where it is today with nothing bad actually happening with the company to support such a drop in price. However while collateral damage maybe a motive, it is not the only reason. Another reason is keeping people away from SINT by making it look like its a scam, allows them to manipulate the price unimpeded, while reducing the likelihood of investigations by the SEC and lawsuits. All the while they point the finger at Sonny and management or even me.
Fails-to-Deliver Data
https://www.sec.gov/data/foiadocsfailsdatahtm
See replied to post for more.
XenaLives
17 hours ago
DD relevant to today's announcement, see replied to post...
Excerpt:
SINTX Technologies Awarded Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants
SINTX will collaborate with the University of Pennsylvania School of Veterinary Medicine (Penn Vet) over the next 24 months to execute this project. The NIH grant will support resourcing and acquisition of materials as well as testing and trials at SINTX and Penn Vet. Upon the successful execution of the Phase II grant application goals, SINTX will have the majority of the benchtop and large animal in vivo data needed to seek FDA regulatory clearance using the 510(k) pathway. Additionally, successful demonstration of infection prevention in vivo will be a critical step towards enabling an antimicrobial device claim. These preliminary animal data will be used to seek future funding from NIH or other Federal agencies to further validate antimicrobial properties of devices made from SN-PEEK.
announced today it has been awarded a Phase II grant of $1,972,826 by the National Institutes of Health (NIH) to develop a 3D printed (3DP) composite silicon nitride – polyetheretherketone (SN-PEEK) spinal implant. This represents the fourth NIH grant awarded to SINTX since the Phase I award for this project was received in September of 2021.
Representing approximately 40% of spine implants within the $10 billion global spine market, PEEK-based devices are favored because of their proven clinical efficacy. Through the development of 3DP SN-PEEK spinal implants, SINTX aims to combine the familiarity and benefits of PEEK with the antibacterial and osteoconductive characteristics of silicon nitride. These composite implants will be manufactured with modern, cost-effective 3D printing technologies.
https://ir.sintx.com/news-events/press-releases/detail/216/sintx-technologies-awarded-phase-ii-nih-grant-for-silicon
XenaLives
18 hours ago
Still impressed:
Prodways Group Patents – Key Insights and Stats
March 21, 2024
Prodways Group has a total of 21 patents globally, out of which 14 have been granted. Of these 21 patents, more than 61% patents are active. The United States of America is where Prodways Group has filed the maximum number of patents, followed by Germany and Europe. Parallelly, the United States of America seems to be the main focused R&D centre and also France is the origin country of Prodways Group.
Prodways Group was founded in 2013. The Prodways Group offers 3D printing services. The business provides printing equipment for the automotive, industrial design, engineering and construction, industrial design, jewelry, footwear, and footwear sectors. As of February 2023, the market cap of Prodways Group is $152 Million.
Do read about some of the most popular patents of Prodways Group which have been covered by us in this article and also you can find Prodways Group patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Prodways Group patent portfolio.
https://insights.greyb.com/prodways-group-patents
boston745
2 days ago
This is a money printing scam has been since ipo Pumps into rs then dilutes to Pennies.
Lets take another look at what TAman87 has said here. This (without identifying what this is) a money printing scam since IPO.
As i said in my previous post, Sintx is not the scam. It has real products/product candidates, no real debt, minimal cash burn considering how expensive R&D is, and has several strategic partnerships with large companies. You want to see a real corporate scam in action, i post about it in the following link. Its a bigger scam than that of Theranos. "Consumer fraud on a massive scale".
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174317282
However i cannot argue against the fact that SINT is being used as a "money printing scam". Ive said that if Sintx was properly valued and SINT reflected that value, then there would not be as many offerings, as many shares "printed" with each offering, and no Reverse Splits. However because Sintx is not properly valued and thus SINT along with it, shorting and naked shorting drives the price lower and thus with each new offering prints a ton more shares then would have occurred otherwise had the price not been shorted into the offering.
Who is making the easy money shorting every offering before and after its closing? Who benefits from massive expansion of shares from every offering? Who benefits shorting before and after every RS? Who needs SINT to print millions more shares to close out their naked short positions? The hfunds that buy the offerings and hold those naked short positions thats who and all those regulars that short with them! They are the ones making easy money using SINT as a "money printing scam". They take advantage of the fact that SINT is insanely undervalued, something i believe they helped create, and the fact that Sintx has to tap markets to fund its R&D. However Sintx continues to develop very valuable IP with those dollars it receives to fund R&D.
https://i.imgur.com/slfDxL5.jpeg
Source of photo:
https://web.archive.org/web/20221128231656/https://static.seekingalpha.com/uploads/sa_presentations/787/14787/original.pdf - Slides 5 & 27
========================================
A basic roadmap laid out of Zimmer's intentions for Sintx back in 2011. This quote predates Sintx vast IP portfolio expansion. Any markets Zimmer Biomet does not currently participate in, that Sintx does, represents potential markets Zimmer Biomet can utilize Sintx to bolster its revenue through licensing as well as diversify those revenue sources.
AnonymousMay 24, 2011 at 3:42 PM
Zimmer is looking at purchasing Amedica flat out for their techology to bolster sales in spine through licensing and to purchase the next generation of hip and knee implants. You heard it here on TSB.
https://web.archive.org/web/20240408163612/https://spineblogger.blogspot.com/2011/05/whos-next.html?m=1
Silicon Nitride = Next Gen Hip implant material
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422432/
Sintx - Zimmer Connection
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174053353
Sintx - Zimmer connection purposefully not disclosed/removed from 2013 IPO paperwork?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174144294
Sintx - Biomet R&D
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174053136
Dr. Pezzotti member of Sintx scientific board and his research for Biomet
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174052660
Zimmer Biomet Hires Si3N4 Coatings Expert for its anti-infective dvision - December 2018
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174115529
Zimmer Biomet pays 2.5m certain R&D payment Q2 2017, Dr Bal's investment company loans $2.5m to Sintx.Q3, 2017
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174152867
Sintx - Morgan Ceramics partnership & NP Aerospace Connections
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174166246
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174166439
Mr Bond, they have a saying in Chicago: 'Once is happenstance. Twice is coincidence. The third time it's enemy action'.
One is an incident, two is a coincidence, three's a pattern, and four is enough for a warrant
boston745
2 days ago
One thing particularly interesting since the 2022 RS was the fact that with each announcement of offering the price of the stock would immediately drop 50% or so. That's before such an offering was even closed. Before new shares hit market. Then, because of the exact mechanism I described in my last post the price would be naked shorted another 50% post offering. So if the price was at 50 cents on announcement of a forthcoming offering, offering price then occurred at .25, and then closed out at 12.5ish post offering. There it stood for awhile until the next halving at 4.7 cents.
No negative news was released by the company to justify these drops, it just dropped because it could. However it did this repeatedly showcasing a pattern which shows purpose and collusion. The one major anomaly was when the stock was trading in the 8-9 dollar range and the offering was announced, for some reason at 5.6. Look at the trading history. The stock price hit a high of $12.14 in the 3 trading days before the offering price was announced at 5.6. Then the next day the price halved the previous days low to the low 3's. Funds naked shorted into that offering from as high as 12.14. SEC needs to investigate the trading that has occurred in regards to SINT and the short & distorting thats gone on via social media.
To keep interested buyers away, funds point to how poorly the stock has traded while ensuring it trades that way to support these types of posts, cyclical in nature. Outside of that shorts mostly have to employ deceptive pratices in their posts. These deceptive practices would not be necessary if the company was as bad as they would have people believe.
Take for example this post on ST.
This is a money printing scam has been since ipo Pumps into rs then dilutes to Pennies.
Sintx isnt a scam in the first place. It does have to raise funds via markets to fund R&D no doubt. But this same poster would have people believe that the company has no products that it's selling. That its a shell company. Not that the company has a material that is "destined to become a leader to replace titanium and other entrenched biomaterials". That quote is backed by scientific study completely unrelated to Sintx. Research into the company Implex to see a comparable materials valuation at acquisition. Take note though that Implex acquisition costs were over 200m with 108m being upfront and the rest coming over the next two years as sales milestones were met. This company had 5m in revenue when Zimmer announced its partnership with it. It had 1 product on the market with several pending when it was acquired in 2003.
The rest of the statement is true in the sense that the more the stock price is driven downward the more shares are released per offering. What's missing from this statement however is the fact that its the hfunds buying the offerings that are benefitting from the massive expansion of shares per offering and each reverse split. This is because they short into every RS knowing another offering will come.
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
========================================
Silicon Nitride = Next Gen Hip Implant Material
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Im guessing the authors meant Sintx Technologies. Amedica being the companies former name before the name was sold to CTL.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422432/
========================================
Electromagnetic fields, metal implant corrosion, and dis-ease it causes
https://i.imgur.com/nLg7SXT.jpg
Cancer-Causing Effects of Orthopaedic Metal Implants in Total Hip Arthroplasty
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11011042/
Oral Cancer around Dental Implants: Are the Clinical Manifestations and the Oncogenic Mechanisms Unique?
https://www.intechopen.com/chapters/79298
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779
boston745
3 days ago
I think my next round of research will be oriented toward showing that hedge funds prefer companies in SIntx position which provide them with near risk free profits and quick liquidity. Meaning these Hfunds want to keep SINT undervalued. Low prices allow for greater returns as % movements are larger with less capital needed. They would also be after control of the stock and to scare investors away to maintain that control. This could be another reason hfunds preform better when companies stocks are in bearish conditions. We all know Hfunds are the ones that engage in P&D activities and they like to use companies management as a scapegoat for their actions.
As shown with the offering round at .25, hedge funds naked shorted from as high as .52 cents before even buying a share. They made millions (paper returns) before even buying the offering and then closed out those naked shorts at .15 or so in the span of like 2-4 days. If they are still around then they successfully shorted from there profiting further. This cycle is why SINT is so undervalued. Hedge funds do not care if long or short but they seem to be more profitable in a bear market (holding short) than bull (holding long) because they can better play the up and down. SINT has been in a bear market conditions since IPO. Its these same hedge funds pumping the price now to increase their profits especially as they'll be shorting the RS because they will get guaranteed profits shorting into the next offering.
Hedge Funds Actively Seek Absolute Returns
Hedge funds lie at the active end of the investing spectrum as they seek positive absolute returns, regardless of the performance of an index or sector benchmark. Unlike mutual funds, which are "long-only" (make only buy-sell decisions), a hedge fund engages in more aggressive strategies and positions, such as short selling, trading in derivative instruments like options, and using leverage (borrowing) to enhance the risk/reward profile of their bets.
This activeness of hedge funds explains their popularity in bear markets. In a bull market, hedge funds may not perform as well as mutual funds, but in a bear market—taken as a group or asset class—they should do better than mutual funds because they hold short positions and hedges.
In hedge funds, liquidity is a key concern for investors.
https://www.investopedia.com/articles/03/112603.asp
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
========================================
Silicon Nitride = Next Gen Hip Implant Material
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Im guessing the authors meant Sintx Technologies. Amedica being the companies former name before the name was sold to CTL.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422432/
========================================
Electromagnetic fields, metal implant corrosion, and dis-ease it causes
https://i.imgur.com/nLg7SXT.jpg
Cancer-Causing Effects of Orthopaedic Metal Implants in Total Hip Arthroplasty
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11011042/
Oral Cancer around Dental Implants: Are the Clinical Manifestations and the Oncogenic Mechanisms Unique?
https://www.intechopen.com/chapters/79298
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779
boston745
3 days ago
This is what a scam looks like TA since you arent able to differentiate. Although i do believe there is a con going on here and that con is to convince people that Sintx's IP value isnt significantly more than it is. That management is more inept than it is. That Sintx isnt working with companies evidence clearly show its working with. This is why accounts like yours TA have to continually resort to deceptive tactics in their posts. The stockprice is clearly being manipulated to help drive these narratives and force those RS you like to point to. IF the stock price properly reflected Sintx IP value, in the hundreds of millions, Sintx wouldnt need to do as many offerings because it could raise more per offering, it wouldnt "print" as many shares, and wouldnt have needed to RS.
My stance on Tesla is its a bigger 'Fake it Until it Makes it Scam' than that of Theranos! A scam thats putting so many lives at risk!
Facebook Cofounder Says Tesla Has Committed "Consumer Fraud on a Massive Scale," Will End in Jail
Heads Will Roll
Amidst a chaotic month for Tesla — even by its continuously plunging standards — Facebook cofounder and multi-billionaire Dustin Moskovitz has made some pretty dire predictions for the automaker, accusing it of committing "consumer fraud on a massive scale."
"This is Enron now, folks," Moskovitz wrote on Threads, referring to the corporation that went bankrupt in 2001 after it was exposed for one of the biggest accounting frauds in history. "It may keep going, but people are going to jail at the end."
No idea about whether Tesla is engaged in book cooking, this is not the first time its been accused of that, but consumer fraud on a mass scale definitely seems accurate. Just look at what falls under fake it until you make it practice and then compare to actual actions taken by Elon Musk and Tesla.
it was arguably a referendum on “fake it till you make it” practices, such as intentionally overstating, and thereby misrepresenting, a fledgling company’s current capabilities, success, or profitability, while banking on the notion that its aspirations will eventually follow the desired trajectory and become a reality.
Elon Musk slashes price for Tesla’s vaunted self-driving tech by a full third—FSD now costs as much as in 2020
Rolled out to a select few three and a half years ago, the highly anticipated beta gave Musk the opportunity to hike the cost of FSD to $10,000. He would continue to urge his loyal customers to buy FSD, since the longer they waited, the more it would cost them.
That’s because Musk repeatedly claimed the price would go up the better the software got and the closer FSD came to driving without human supervision, at which point, he boasted, it would be worth over $100,000. Initially he also kept his word: Two subsequent hikes, which culminated in a record increase to $15,000 in 2022, were pushed through despite no substantive progress having been made.
The issue was that take rates had plummeted after customers broadly gave up on his annual promise of a breakthrough next year. He had to resort last month to compulsory trials when new owners picked up their car for the first time. Attempts to license the technology to rival carmakers also collapsed, he admitted in January.
In a way, Musk has given up on FSD as well. In what appears to be an acknowledgement that existing owners will not experience their cars turning into robo-taxis overnight—what Musk called Tesla’s “ChatGPT moment”—he opted to simply end the beta test in favor of calling the software “supervised FSD.” This opens up the chance to recognize nearly $926 million in deferred revenue
You can see clearly that Elon Musk has overstated what his tech could do and how quickly it could do it repeatedly. Not only that he also gave it enomous valuation saying FSD per vehicle would be worth 100k. This was crucial in Teslas valuation skyrocketing and helped propel sales of its vehicles well beyond what would have happened otherwise had these claims not been made.
Elon Musk’s Big Lie About Tesla Is Finally Exposed
Not long before the pandemic reared its ugly head, the brilliant, serial entrepreneur Elon Musk promised to roll out an Uber-like service enabled by self-driving Tesla vehicles. According to Musk, Tesla owners could expect to earn up to $30,000 per year in extra cash by lending their Teslas out to anyone in need of a ride. Owners and customers would transact on the “Tesla network.”
This self-driving technology already exists. At this point, the network can go live very soon, opening the world to an exciting new way to make money while you sleep.
Back in 2016, Elon Musk claimed that Tesla cars could “drive autonomously with greater safety than a person. Right now.” It was a lie, one that sent Tesla’s stock price soaring — and made Musk among the wealthiest people on the planet. That lie is now falling apart in the face of a new recall of 2 million Teslas. It’s also revealing to the broader public what close observers of Tesla have always known (and the company itself admits in the fine print of its legal agreements): Tesla’s so-called “self driving” technology works fine — as long as there’s a human behind the wheel, alert at all times.
By this time Musk had MCed numerous stock price-spiking hype events around the technology, and had been collecting deposits from customers since late 2016 for a “Full Self-Driving” version of the technology. Despite the reported deaths and clear evidence that the only video of a driverless Tesla was heavily staged, even Musk admits that his hype around self-driving technology has been the central factor in the recent growth of his wealth to titanic proportions.
Quote Sources:
https://finance.yahoo.com/news/facebook-cofounder-says-tesla-committed-135001013.html
https://fortune.com/2024/04/22/elon-musk-tesla-price-cuts-earnings-fsd-supervised-full-self-driving-beta/
https://corpgov.law.harvard.edu/2022/01/30/theranos-the-limits-of-the-fake-it-till-you-make-it-strategy/
https://www.rollingstone.com/culture/culture-commentary/elon-musk-tesla-crash-1234930544/
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
========================================
Silicon Nitride = Next Gen Hip Implant Material
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Im guessing the authors meant Sintx Technologies. Amedica being the companies former name before the name was sold to CTL.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422432/
========================================
Electromagnetic fields, metal implant corrosion, and dis-ease it causes
https://i.imgur.com/nLg7SXT.jpg
Cancer-Causing Effects of Orthopaedic Metal Implants in Total Hip Arthroplasty
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11011042/
Oral Cancer around Dental Implants: Are the Clinical Manifestations and the Oncogenic Mechanisms Unique?
https://www.intechopen.com/chapters/79298
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779
boston745
4 days ago
Looks like TA, that madg posted that so you could then post that im posting BS when i replied. I realize that me posting this could add to the illusion that Sintx is a scam. Yet i persist.
Its funny that Sintx selling its spinal IP and Amedica name to CTL is actually action aligned with Zimmer Biomets goal to license Sintx core tech outside of Hip/Knee as stated back in 2011.
If masks, and/or any other Si3n4 imbued fabric product, end up being commercialized with Solventum at any point, which would be ironic considering bashers were the first to name drop 3M before Hanson even left Zimmer Biomet for its spin-off Solventum, then everything that happened with O2 makes sense. So much of what happens with Sintx makes sense if you understand that Sonny is aligning Sintx with Zimmer Biomet strategic goals.
AnonymousMay 24, 2011 at 3:42 PM
Zimmer is looking at purchasing Amedica flat out for their techology to bolster sales in spine through licensing and to purchase the next generation of hip and knee implants. You heard it here on TSB.
https://web.archive.org/web/20240408163612/https://spineblogger.blogspot.com/2011/05/whos-next.html?m=1
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
========================================
Silicon Nitride = Next Gen Hip Implant Material
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Im guessing the authors meant Sintx Technologies. Amedica being the companies former name before the name was sold to CTL.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422432/
========================================
Electromagnetic fields, metal implant corrosion, and dis-ease it causes
https://i.imgur.com/nLg7SXT.jpg
Cancer-Causing Effects of Orthopaedic Metal Implants in Total Hip Arthroplasty
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11011042/
Oral Cancer around Dental Implants: Are the Clinical Manifestations and the Oncogenic Mechanisms Unique?
https://www.intechopen.com/chapters/79298
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779
boston745
4 days ago
If Sonny is aligning Sintx with Zimmer Biomets core goals as I think then Sintx isnt being mismanaged but its actions simply misunderstood. That misunderstanding is being exploited by those shorting SINT and trying to convey mismanagement. Again the core Ip is very valuable and has expanded immensely. Yet that value is not reflected at all in the stockprice or marketcap.
But its so much more than simply an acquisition madg and you should know that by now! I post this with almost every post. Pay particular attention to section 3 & 1. 2 is just reinforment that Si3N4 is next gen Hip/Knee material confirming exactly why Zimmer Biomet would want the tech for its most important product lines.
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
========================================
Silicon Nitride = Next Gen Hip Implant Material
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Im guessing the authors meant Sintx Technologies. Amedica being the companies former name before the name was sold to CTL.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422432/
========================================
Electromagnetic fields, metal implant corrosion, and dis-ease it causes
https://i.imgur.com/nLg7SXT.jpg
Cancer-Causing Effects of Orthopaedic Metal Implants in Total Hip Arthroplasty
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11011042/
Oral Cancer around Dental Implants: Are the Clinical Manifestations and the Oncogenic Mechanisms Unique?
https://www.intechopen.com/chapters/79298
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779
boston745
6 days ago
Yesterdays short volume. Very high percent short via the American Stock Exchange and Montreal Stock Exchange is pretty consistent in the 30s. 87% of volume trading via NASD ASF.
Trade Facility Date Symbol Short Volume Short Exempt Volume Total Volume Market
NCTRF 2024-04-23 SINT 95800 0 117803 B
NQTRF 2024-04-23 SINT 8768340 1028245 14801271 Q
NYTRF 2024-04-23 SINT 668413 0 2051632 N
9,532,553.00 1,028,245.00 16,970,706.00 56.17%
B = 81% Short
N = 33% short
Q = 59% short
B = American Stock Exchange
N = Montreal Stock Exchange
Q = NASD ADF
https://www.finra.org/finra-data/browse-catalog/short-sale-volume-data
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
========================================
Silicon Nitride = Next Gen Hip Implant Material
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Im guessing the authors meant Sintx Technologies. Amedica being the companies former name before the name was sold to CTL.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422432/
========================================
Electromagnetic fields, metal implant corrosion, and dis-ease it causes
https://i.imgur.com/nLg7SXT.jpg
Cancer-Causing Effects of Orthopaedic Metal Implants in Total Hip Arthroplasty
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11011042/
Oral Cancer around Dental Implants: Are the Clinical Manifestations and the Oncogenic Mechanisms Unique?
https://www.intechopen.com/chapters/79298
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779
boston745
6 days ago
No revenue/ROI.
Why would you go after revenue?
Because to make money.
No.
If you show revenue, people will ask,
"How much?" And it will never be enough.
The company that was the 1 00xer,
the 1,000xer, becomes the 2x dog.
But if you have no revenue,
you can say you're pre-revenue.
You're a potential pure play.
It's not about how much you earn,
it's about what you're worth.
And who's worth the most?
Companies that lose money.
Pinterest, Snapchat, no revenue.
Amazon has lost money every fucking quarter
for the last 20 fucking years
and that Bezos motherfucker is the king.
The king.
There's no revenue.
No one wants to see revenue. Go.
I just thought that mainly
the goal of companies is to make money.
Yeah, no, no, no. That's not how it works.
I don't want to make
a little bit of money every day.
I want to make a fuckton of money all at once.
ROI.
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
========================================
Silicon Nitride = Next Gen Hip Implant Material
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Im guessing the authors meant Sintx Technologies. Amedica being the companies former name before the name was sold to CTL.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422432/
========================================
Electromagnetic fields, metal implant corrosion, and dis-ease it causes
https://i.imgur.com/nLg7SXT.jpg
Cancer-Causing Effects of Orthopaedic Metal Implants in Total Hip Arthroplasty
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11011042/
Oral Cancer around Dental Implants: Are the Clinical Manifestations and the Oncogenic Mechanisms Unique?
https://www.intechopen.com/chapters/79298
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779
Level up your trading with our powerful tools and real-time insights all in one place.
benhor
17 hours ago
green maschine
24 hours ago
Hot Features
Premium
